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Cell lineage tracing revealed the reversion of liver tumor cells to normal hepatocytes during tumor regression of xmrk transgenic zebrafish Yan Li, Zhiyuan Gong National University of Singapore, Singapore
Our group has previously established several inducible hepatocellular carcinoma (HCC) models in zebrafish by transgenic expression of selected oncogenes. One common and important feature of these liver tumor models is the reversibility of tumor after suppression of oncogene expression by removing chemical inducer. This phenomenon could be useful to model the process of targeted cancer therapy in human. However, the question remains unanswered is whether the tumor cells have been eliminated or reverted to normal cells. Hepatocellular carcinoma (HCC) now is the sixth leading cancer worldwide and causes millions of death annually. HCC shows gender disparity during carcinogenesis, which means that men have significantly higher incidence and mortality rate of HCC than women. HCC seldom shows regression among patients, and whether the gender disparity shown in HCC regression now is unclear due to low frequency of the HCC regression and the few research on this phenomenon. In our lab, the transgenic zebrafish with xmrk and c-myc expression in liver showed rapid development of HCC during induction and rapid regression after withdrawal of the inducer, which makes it an appropriate tool for investigating the HCC regression. Sex hormones are believed to play an important role in gender disparity of HCC progression. In present study, the xmrk/myc adult fish with well-progressed HCC were recovering, along with different sex hormone treatments. After treatments, it showed that the HCC regression were accelerated by exogenous estrogen and slowed down by androgen treatment. Overall, our study presented that HCC regression showed significant gender disparity, and sex hormones affect regression of HCC, which may provide a new idea about HCC therapy. 
